CLOUGH CAPITAL PARTNERS L P - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 30 filers reported holding KURA ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2021$529,000
-26.2%
25,3610.0%0.03%
-9.4%
Q1 2021$717,000
-13.4%
25,3610.0%0.03%
-45.8%
Q4 2020$828,000
-46.6%
25,361
-49.9%
0.06%
-47.3%
Q3 2020$1,552,000
+41.0%
50,661
-25.0%
0.11%
+3.7%
Q2 2020$1,101,000
+63.8%
67,5610.0%0.11%
+61.2%
Q1 2020$672,000
-30.9%
67,561
-4.4%
0.07%
-19.3%
Q4 2019$972,000
-11.8%
70,661
-2.8%
0.08%
-8.8%
Q3 2019$1,102,000
-26.8%
72,661
-5.0%
0.09%
-38.5%
Q2 2019$1,506,000
+13.1%
76,461
-4.7%
0.15%
+27.6%
Q1 2019$1,332,000
+18.2%
80,2610.0%0.12%
-12.1%
Q4 2018$1,127,000
-19.8%
80,2610.0%0.13%
-0.8%
Q3 2018$1,405,000
-38.9%
80,261
-36.5%
0.13%
-35.1%
Q2 2018$2,300,000
-27.2%
126,361
-25.0%
0.20%
-32.1%
Q1 2018$3,159,000
-2.9%
168,461
-20.8%
0.30%
+11.4%
Q4 2017$3,255,000
-3.2%
212,761
-5.4%
0.27%
+20.4%
Q3 2017$3,362,000
-14.1%
224,861
-46.6%
0.22%
-17.3%
Q2 2017$3,915,000
-11.1%
420,997
-15.9%
0.27%
-2.9%
Q1 2017$4,406,000
+13.1%
500,697
-24.1%
0.28%
+8.5%
Q4 2016$3,895,000
-7.1%
660,089
-1.6%
0.26%
+17.8%
Q3 2016$4,193,000
+106.9%
670,859
-10.3%
0.22%
+102.8%
Q2 2016$2,027,000
-53.1%
748,039
-29.9%
0.11%
-47.1%
Q1 2016$4,322,000
-52.7%
1,067,133
-1.8%
0.20%
-52.2%
Q4 2015$9,133,0001,087,2330.43%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders